BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Mar 26, 2025; 17(3): 101768
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.101768
On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications
Alexander E Berezin
Alexander E Berezin, Internal Medicine-II, Paracelsus Medical University Salzburg, Salzburg 5020, Austria
Author contributions: Berezin AE is the sole author of the manuscript.
Conflict-of-interest statement: There are no conflicts of interests.
Corresponding author: Alexander E Berezin, MD, PhD, FACC, FESC, Doctor, Professor, Internal Medicine-II, Paracelsus Medical University Salzburg, Strubergasse, 21, Salzburg 5020, Austria. aeberezin@gmail.com
Received: September 25, 2024
Revised: February 17, 2025
Accepted: February 25, 2025
Published online: March 26, 2025
Processing time: 176 Days and 16 Hours
Core Tip

Core Tip: Contemporary hybrid strategy of hemostasis through the use of vascular closure devices has demonstrated great benefits over standard rescue techniques (open surgery or vascular compression at the site of vascular intervention) in reducing vascular-related complications and improving patient satisfaction. Percutaneous decannulation with the MANTA Vascular Closure Device is an effective and safe procedure to provide low-risk vascular assess for a long time for individuals requiring veno-arterial-extracorporeal membrane oxygenation, while specific approach based on other variants of vascular closure devices or open surgery should be tailored to the actual patient's clinical characteristics and prognosis.